SKI Market

Indian Indices

Nifty

25,986.00 -46.20
(-0.18%)

Sensex

85,106.81 -31.46
( -0.04%)

Bank Nifty

59,348.25 74.45
( 0.13%)

Nifty IT

37,825.25 284.00
( 0.76%)

Global Indices

Nasdaq

47,501.07 190.74
(0.40%)

Dow Jones

6,850.51 16.88
(0.25%)

Hang Seng

49,986.70 683.25
(1.39%)

Nikkei 225

9,708.56 6.76
(0.07%)

Forex

USD-INR

89.54 0.20
(0.23%)

EUR-INR

103.99 0.41
(0.39%)

GBP-INR

118.45 0.28
(0.24%)

JPY-INR

0.58 0.00
(0.76%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

Indo US Bio-Tech standalone net profit declines 20.87% in the September 2025 quarter

Nov 16,2025

Net profit of Indo US Bio-Tech declined 20.87% to Rs 3.45 crore in the quarter ended September 2025 as against Rs 4.36 crore during the previous quarter ended September 2024. Sales rose 39.15% to Rs 30.85 crore in the quarter ended September 2025 as against Rs 22.17 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	30.85	22.17	39
OPM %	13.48	23.14	-
PBDT	3.77	4.63	-19
PBT	3.56	4.45	-20
NP	3.45	4.36	-21

25,986.00 -46.20 (-0.18%)

85,106.81 -31.46 ( -0.04%)

59,348.25 74.45 ( 0.13%)

37,825.25 284.00 ( 0.76%)

47,501.07 190.74 (0.40%)

6,850.51 16.88 (0.25%)

49,986.70 683.25 (1.39%)

9,708.56 6.76 (0.07%)

89.54 0.20 (0.23%)

103.99 0.41 (0.39%)

118.45 0.28 (0.24%)

0.58 0.00 (0.76%)